If you need more lookups,
subscriptions start at $34 USD/month.
Greg Donoho Location
Indianapolis, IN, US
Greg Donoho Work
Director - In Vivo Pharmacology @ (January 2020 - Present)
Director @ Eli Lilly and Company (March 2014 - January 2020)
Principal Research Scientist @ Eli Lilly and Company (October 2009 - February 2014)
Senior Research Scientist @ Eli Lilly and Company (September 2003 - September 2009)
Principal Research Scientist @ (April 2001 - July 2003)
Group Leader @ Genometrix Genomics Incorporated (February 2000 - April 2001)
Research Scientist @ (January 1997 - February 2000)
Greg Donoho Education
Stanford University
PhD (Biochemistry)
1989-1996
Purdue University
BS (Biochemistry)
1985-1989
Mt. Vernon Community School Corporation 1981-1985
Greg Donoho Skills
Drug Development
Translational Research
Biomarkers
Preclinical models
Drug Discovery
Oncology
In Vitro
Assay Development
Biochemistry
Biotechnology
Cell
Cell Biology
Cell Culture
Clinical Development
Clinical Trials
Drug Design
High Throughput Screening
Translational Medicine
In Vivo
Immunology
Life Sciences
Molecular Biology
Lifesciences
Monoclonal Antibodies
Pharmacology
Pharmaceutical Industry
Greg Donoho Summary
Greg Donoho, based in Indianapolis, IN, US, is currently a Director - In Vivo Pharmacology at Loxo Oncology, Inc.. Greg Donoho brings experience from previous roles at Eli Lilly and Company and Pfizer. Greg Donoho holds a 1989 - 1996 PhD in Biochemistry @ Stanford University. With a robust skill set that includes Drug Development, Translational Research, Biomarkers, Preclinical models, Drug Discovery and more. Greg Donoho has 1 emails on RocketReach.
Looking for a different Greg Donoho?
Find contact details for 700 million professionals.